Mental and Behavioural Disorders
Conditions
Interventions
Repetitive transcranial magnetic stimulation and non stimulants
Sham rTMS and Atomoxetine
Sponsors
FACULTY OF MEDCINE AIN SHAMS UNIVERSITY
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with ADHD according to DSM IV Age ranges 7-12 years old All patients will be on the same type of medications throughout the duration of the study (Atomoxetine 1.2 mg/kg/day)
Exclusion criteria
Exclusion criteria: Factors that might increase the risk of seizure with TMS such as a history of a seizure disorder, febrile seizures during childhood, known brain lesions, or a history of major head trauma involving loss of consciousness for more than 5 minutes. Specific contraindications to magnetic stimulation such as any metallic object implanted in the skull (with the exception of oral dental devices), an implanted medication pump or cochlear implant, implanted intra-cardiac lines or pacemaker. Comorbid diagnosis of autism spectrum disorder, bipolar disorder, obsessive-compulsive disorder, conduct disorder, Tourette disorder or other tic disorders, schizophrenia, schizoaffective disorder, or any other psychotic disorder. Any other neurological disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy was assessed as a primary outcome by changes in the Clinical Global Impression-Improvement (CGI-I) and childrens global assessment scale and the change will be compared between the 2 groups | — |
Secondary
| Measure | Time frame |
|---|---|
| The change in the scores of revised conners parent rating scale Long form CPRS-R-L from baseline, midpoint and end of the study will be compared between the 2 groups. | — |
Countries
Egypt
Contacts
Public Contacthussein elkholy
Professor of Psychiatry
Outcome results
None listed